René Djurup
Direktor/Vorstandsmitglied bei Bioneer A/S
Profil
René Djurup is currently a Director at Bioneer A.
Previously, he worked as the Head of Research & Development at Novo Nordisk A from 1993 to 1997 and as the Chief Technical Officer at Bavarian Nordic A from 2003 to 2008.
He also held a position as Principal at Copenhagen University Hospital.
Dr. Djurup received a graduate degree from the University of Copenhagen in 1987 and a doctorate degree from the same institution in 1978.
Aktive Positionen von René Djurup
| Unternehmen | Position | Beginn |
|---|---|---|
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von René Djurup
| Unternehmen | Position | Ende |
|---|---|---|
| BAVARIAN NORDIC A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
| NOVO NORDISK A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1997 |
| Copenhagen University Hospital | Corporate Officer/Principal | - |
Ausbildung von René Djurup
| University of Copenhagen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| BAVARIAN NORDIC A/S | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Health Technology |
